IDH2 and astrocytoma (excluding glioblastoma): The majority of IDH-mutant astrocytomas possess methylated MGMT promoters, and compared to IDH-wildtype glioblastomas, IDH-mutant tumours show significantly higher MGMT promoter methylation.